Docket
117th Congress · HOUSE BILLBILL

H.R. 2148 — Prescription Drug Price Relief Act of 2021

“To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.”

Health
Introduced Mar 23, 2021
Last action Oct 19, 2021
Pipeline · Bill → Law
Step 1
Introduced
Mar 23, 2021
Step 2
Referred
Oct 19, 2021
E&C · Judiciary
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 8 sectionsIntroduced in House
Timeline · 5 actions
Oct 19, 2021
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Mar 24, 2021
Referred to the Subcommittee on Health.
Mar 23, 2021
Introduced in House
Mar 23, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 23, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.